Publicaciones en las que colabora con JOSE LUIS ORTIZ BELDA (44)

2019

  1. Pharmacological profile of AZD8871 (LAS191351), a novel inhaled dual M3 receptor antagonist/β2-adrenoceptor agonist molecule with long-lasting effects and favorable safety profile

    Journal of Pharmacology and Experimental Therapeutics, Vol. 370, Núm. 1, pp. 127-136

2018

  1. Deciphering function of the pulmonary arterial sphincters in loggerhead sea turtles (Caretta caretta)

    Journal of Experimental Biology, Vol. 221, Núm. 23

  2. JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study

    Thorax, Vol. 73, Núm. 6, pp. 519-529

2017

  1. Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist /β2-adrenoceptor agonist (MABA) molecule

    Pulmonary Pharmacology and Therapeutics, Vol. 46, pp. 1-10

2016

  1. Evaluation of mucociliary clearance by three dimension micro-CT-SPECT in Guinea pig: Role of Bitter taste agonists

    PLoS ONE, Vol. 11, Núm. 10

  2. Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: An ex vivo/in vitro study

    European Respiratory Journal, Vol. 47, Núm. 6, pp. 1737-1749

2013

  1. Phosphodiesterase-4 inhibition improves corticosteroid insensitivity in pulmonary endothelial cells under oxidative stress

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 68, Núm. 1, pp. 64-73

2012

  1. Bosentan inhibits cigarette smoke-induced endothelin receptor expression in pulmonary arteries

    European Respiratory Journal, Vol. 39, Núm. 4, pp. 927-938

2010

  1. Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: Molecular and functional consequences

    British Journal of Pharmacology, Vol. 161, Núm. 7, pp. 1599-1615

  2. Cigarette smoke-induced pulmonary endothelial dysfunction is partially suppressed by sildenafil

    European Journal of Pharmaceutical Sciences, Vol. 39, Núm. 5, pp. 363-372

  3. Direct effect of cigarette smoke on human pulmonary artery tension

    Pulmonary Pharmacology and Therapeutics, Vol. 23, Núm. 3, pp. 222-228

2000

  1. Histamine up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils

    Inflammation Research, Vol. 49, Núm. 11, pp. 600-609

  2. β-adrenoceptor stimulation up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 361, Núm. 4, pp. 410-417

1998

  1. Effects of fenspiride on human bronchial cyclic nucleotide phosphodiesterase isoenzymes: Functional and biochemical study

    European Journal of Pharmacology, Vol. 341, Núm. 1, pp. 79-86

1997

  1. Halothane inhibits endothelium-dependent relaxation elicited by acetylcholine in human isolated pulmonary arteries

    European Journal of Pharmacology, Vol. 326, Núm. 2-3, pp. 175-181

  2. Inhibitory effects of N-acetylcysteine on superoxide anion generation in human polymorphonuclear leukocytes

    Journal of Pharmacy and Pharmacology, Vol. 49, Núm. 5, pp. 525-529

1996

  1. Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 353, Núm. 2, pp. 200-206

1995

  1. INHIBIDORES SELECTIVOS DE FOSFODIESTERASAS: BASES FARMACOLOGICAS Y USO CLINICO POTENCIAL

    Farmacia Clinica, Vol. 12, Núm. 6, pp. 413-420

  2. Leukotriene receptors on human pulmonary vascular endothelium

    British Journal of Pharmacology, Vol. 115, Núm. 8, pp. 1382-1386

1994

  1. Effects of Ca2+ channel antagonists and benzodiazepine receptor ligands in normal and skinned rat urinary bladder

    European Journal of Pharmacology, Vol. 255, Núm. 1-3, pp. 157-165